ROBOTICS & AUTOMATION
Empowering Progress
Up to 25% off Essentials Robotics and Automation titles

Animal Models for Medications Screening to Treat Addiction, the latest volume in the International Review of Neurobiology series, provides a comprehensive overview of the state-of-… Read more
ROBOTICS & AUTOMATION
Up to 25% off Essentials Robotics and Automation titles
Animal Models for Medications Screening to Treat Addiction, the latest volume in the International Review of Neurobiology series, provides a comprehensive overview of the state-of-the-art research on the topic. It reviews the current knowledge and understanding in the field, presenting a starting point for researchers and practitioners entering the field.
Neurobiologists, neuroscientists, pharmacologists, addiction scientists, and researchers studying the animal models and drug discovery research for drug addiction as well as clinical researchers in academia, industry or the government interested in behavioral neuroscience and/or behavioral genetics, especially as it relates to Addiction Medicine and Addiction Psychiatry. This book can be used as a reference book for medication development research in the addiction field.
1. Animal models of Methamphetamine-abuse to screen pharamcotherapeutic interventions for addiction
Arlington George Wilson
2. Identification of treatment targets in a genetic mouse model of voluntary methamphetamine drinking
Tamara J. Phillips
3. Animal models for screening drugs to treat cannabis dependence: a translational perspective
Bernard Le Foll
4. Rodent models to screen clinically-effective smoking cessation agents
Mohammed Shoaib
5. An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism
Howard C. Becker
6. Variance in Ethanol Intake and Its Correlates Among Wistar Rats from Different Vendors: Its Impact on Medications Screening to Treat Alcohol Abuse and Dependence
Ingrid Nylander
7. Rat Lines Genetically Selected to Develop High Alcohol-Consuming Behavior and Dependence: Behavioral Correlates Paralleling Features Found in the Dually-Diagnosed Patient
Erika Roman
8. Screening Signature Compounds in the P and HAD Rat Animal Models of Alcoholism: A Survey of Results Focusing on Statistical Power and Effect Size
Richard L. Bell
9. Animal models and the development of vaccines to treat and/or prevent substance use disorders
Colin N. Haile
10. Genes and Excessive Alcohol Intake: Using Mutant Mice to Pinpoint Molecular Systems as Drugable Targets to Treat Alcohol Use Disorders
Robert Adron Harris
11. Gene Targeting Studies of Physical and Affective States of Alcohol Withdrawal in Rodents
Gian D. Greenberg
12. Abstinence Conflict Model: Toward an Optimal Animal Model for Human Drug Abstinence
Joshua Alan Peck
13. Prairie vole as a model to screen medications for the treatment of alcoholism and addictions: A Mini-Review
Andrey E. Ryabinin
14. Animal Models for Medication Development and Application to Treat Fetal Alcohol Effects
Susan Barron
15. Using In Vitro Electrophysiological Approaches to Screen for Novel Drug Targets: Accumbal Plasticity as an Engram of Alcohol Dependence
Richard Morrisett
16. C. elegans: A Behavioral Model System to Screen Medications for the Treatment of Addiction
Eric A. Engleman
17. Animal Models for Medications Screening Targeting the Treatment of Addiction: Caveats and Future Directions
Shafiqur Rahman
RB
SR
Dr. Rahman's research focus is drug discovery in neuropharmacology, i.e. the development of novel therapeutic candidates for the treatment of alcohol/nicotine addiction and neuropsychiatric disorders using animal models. His research resulted in over 200 publications/presentations, including peer-reviewed scientific articles, reviews, book chapters, meeting abstracts and seminar presentations. Dr. Rahman served on numerous scientific review panels and editorial boards of several scientific Journals. He has authored or edited multiple books or Journals in drug addiction and neuropharmacology field. Dr. Rahman is also affiliated with a number of professional organizations, including Society for Neuroscience and American Society for Pharmacology and Experimental Therapeutics.